PL321711A1 - Methods of and compositions for controlling the cd28 expression - Google Patents
Methods of and compositions for controlling the cd28 expressionInfo
- Publication number
- PL321711A1 PL321711A1 PL96321711A PL32171196A PL321711A1 PL 321711 A1 PL321711 A1 PL 321711A1 PL 96321711 A PL96321711 A PL 96321711A PL 32171196 A PL32171196 A PL 32171196A PL 321711 A1 PL321711 A1 PL 321711A1
- Authority
- PL
- Poland
- Prior art keywords
- expression
- compositions
- controlling
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
- C12N2310/151—Nucleic acids forming more than 2 strands, e.g. TFOs more than 3 strands, e.g. tetrads, H-DNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38704195A | 1995-02-09 | 1995-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL321711A1 true PL321711A1 (en) | 1997-12-22 |
Family
ID=23528194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL96321711A PL321711A1 (en) | 1995-02-09 | 1996-02-05 | Methods of and compositions for controlling the cd28 expression |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0810882A4 (en) |
HU (1) | HUP9801629A3 (en) |
PL (1) | PL321711A1 (en) |
WO (1) | WO1996024380A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
IT1277025B1 (en) * | 1995-12-04 | 1997-11-04 | Cooperativa Centro Ricerche Po | CLASS OF PHOSPHODIESTERIC OLIGONUCLEOTIDES WITH CYTOTOXIC ACTIVITY PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE |
AU5720098A (en) * | 1996-12-27 | 1998-07-31 | Icn Pharmaceuticals, Inc. | G-rich oligo aptamers and methods of modulating an immune response |
WO2000014217A2 (en) * | 1998-09-03 | 2000-03-16 | Coley Pharmaceutical Gmbh | G-motif oligonucleotides and uses thereof |
WO2002022809A2 (en) | 2000-09-15 | 2002-03-21 | Coley Pharmaceutical Gmbh | PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
US20120252869A1 (en) * | 2009-07-24 | 2012-10-04 | Opko Curna, Llc | Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
CN102791861B (en) | 2009-09-25 | 2018-08-07 | 库尔纳公司 | FLG relevant diseases are treated by adjusting expression and the activity of Filaggrin (FLG) |
EP2931893A1 (en) * | 2012-12-13 | 2015-10-21 | Universität Leipzig | T-cell modulation by exon skipping |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0575537A1 (en) * | 1991-03-08 | 1993-12-29 | Cytomed, Inc. | Soluble cd28 proteins and methods of treatment therewith |
US6664107B1 (en) * | 1993-05-26 | 2003-12-16 | Ontario Cancer Institute, University Health Network | CD45 disrupted nucleic acid |
-
1996
- 1996-02-05 WO PCT/US1996/001507 patent/WO1996024380A1/en not_active Application Discontinuation
- 1996-02-05 HU HU9801629A patent/HUP9801629A3/en unknown
- 1996-02-05 PL PL96321711A patent/PL321711A1/en unknown
- 1996-02-05 EP EP96909477A patent/EP0810882A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
HUP9801629A2 (en) | 1998-10-28 |
WO1996024380A1 (en) | 1996-08-15 |
EP0810882A4 (en) | 1999-05-19 |
EP0810882A1 (en) | 1997-12-10 |
HUP9801629A3 (en) | 2000-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5636898A (en) | Methods and compositions for controlling plant development | |
AU5404094A (en) | Method for controlling o-desulfation of heparin and compositions produced thereby | |
AU5259296A (en) | Flavones and coumarins as agents for the treatment of athero sclerosis | |
AU5529596A (en) | Methods and compositions related to stereolithography | |
AU5399898A (en) | Method and compositions for weight control | |
PL323736A1 (en) | Composition maintaining release of non-aggregable erythropoietin | |
EG23934A (en) | Poroxetine controlled release compositions | |
GR3029427T3 (en) | Novel method for the control of biodegradation | |
IL123632A0 (en) | Compositions and methods for controlling harmful fungi | |
AU4802496A (en) | Underarm compositions | |
AU671577B3 (en) | Compositions and methods for the control of smoking | |
AU2259897A (en) | Methods and compositions for the simultaneous control of rootdiseases | |
IL123423A0 (en) | Compositions and methods for controlling harmful fungi | |
IL123631A0 (en) | Compositions and methods of controlling harmful fungi | |
AU6889496A (en) | Suspension for construction machines and method of controlling the same | |
HUP9802997A3 (en) | Antisudorific and/or deodorant compositions | |
PL321711A1 (en) | Methods of and compositions for controlling the cd28 expression | |
AU4468093A (en) | Composition and methods for the generation of bone | |
AU5813894A (en) | Deodorant composition | |
EP0446844A3 (en) | Cycloconverter and the method of controlling the same | |
AU6274694A (en) | Methods and compositions for the inhibition of complement activation | |
AU5526196A (en) | Compositions for the treatment of dandruff | |
AU5699396A (en) | Compositions for the treatment of skin conditions | |
EP0583687A3 (en) | Method for the preparation of substituted methoxyphenols and microorganisms therefore | |
AU4571493A (en) | Method and composition for controlling cockroaches |